• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intermittent androgen deprivation in advanced prostate cancer.

作者信息

de Reijke T M

机构信息

Department of Urology, University of Amsterdam, The Netherlands.

出版信息

Urol Res. 1997;25 Suppl 2:S63-6. doi: 10.1007/BF00941990.

DOI:10.1007/BF00941990
PMID:9144889
Abstract
摘要

相似文献

1
Intermittent androgen deprivation in advanced prostate cancer.晚期前列腺癌的间歇性雄激素剥夺疗法
Urol Res. 1997;25 Suppl 2:S63-6. doi: 10.1007/BF00941990.
2
Study changes how physicians treat metastatic prostate cancer: intermittent hormone therapy not as effective as continuous hormone therapy, authors say.研究改变了医生治疗转移性前列腺癌的方式：作者称，间歇性激素疗法不如持续性激素疗法有效。
Cancer. 2013 Sep 1;119(17):3103-4. doi: 10.1002/cncr.28314.
3
Androgen deprivation therapy for prostate cancer.前列腺癌的雄激素剥夺疗法。
J Urol. 2007 Oct;178(4 Pt 1):1148. doi: 10.1016/j.juro.2007.07.066. Epub 2007 Aug 14.
4
Effect of delayed maximal androgen blockade therapy for patients with advanced prostate cancer who fail to respond to initial androgen deprivation monotherapy.延迟最大雄激素阻断治疗对初始雄激素剥夺单药治疗失败的晚期前列腺癌患者的影响。
Jpn J Clin Oncol. 2010 Dec;40(12):1154-8. doi: 10.1093/jjco/hyq103. Epub 2010 Jul 20.
5
Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects.随机 FinnProstate 研究 VII 中采用间歇性或连续性雄激素剥夺治疗的晚期前列腺癌：生活质量和不良反应。
Eur Urol. 2013 Jan;63(1):111-20. doi: 10.1016/j.eururo.2012.07.040. Epub 2012 Jul 27.
6
Intermittent androgen suppression. Too good to be true?间歇性雄激素抑制。好得难以置信？
Scand J Urol Nephrol Suppl. 1999;203:45-9. doi: 10.1080/003655999750169376.
7
[Current strategies of intermittent hormone therapy in prostate cancer].[前列腺癌间歇性激素治疗的当前策略]
Vopr Onkol. 2011;57(2):260-4.
8
Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma.前列腺腺癌间歇性与持续性雄激素剥夺治疗期间嗜铬粒蛋白A血清水平的变化
Prostate. 2003 May 15;55(3):168-79. doi: 10.1002/pros.10222.
9
A case of abiraterone acetate withdrawal.一例醋酸阿比特龙撤药病例。
Eur Urol. 2013 Sep;64(3):517-8. doi: 10.1016/j.eururo.2013.06.013. Epub 2013 Jun 19.
10
Serum testosterone level to predict the efficacy of sequential use of antiandrogens as second-line treatment following androgen deprivation monotherapy in patients with castration-resistant prostate cancer.血清睾酮水平预测抗雄激素序贯治疗在去势抵抗性前列腺癌患者中作为雄激素剥夺单药治疗二线治疗的疗效。
Jpn J Clin Oncol. 2011 Mar;41(3):405-10. doi: 10.1093/jjco/hyq193. Epub 2010 Oct 14.

本文引用的文献

1
Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council.在一项基于全国社区的项目中，血清前列腺特异性抗原检测和直肠指检用于前列腺癌的早期检测。前列腺癌教育委员会。
Urology. 1996 Jun;47(6):863-9. doi: 10.1016/s0090-4295(96)00061-1.
2
The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.抗雄激素撤药综合征。一大群未经选择的晚期前列腺癌患者的经验。
Cancer. 1995 Oct 15;76(8):1428-34. doi: 10.1002/1097-0142(19951015)76:8<1428::aid-cncr2820760820>3.0.co;2-t.
3
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.
一项随机III期试验的结果，该试验旨在评估锶-89辅助局部外照射在治疗内分泌抵抗性转移性前列腺癌中的疗效。
Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):805-13. doi: 10.1016/0360-3016(93)90309-j.
4
Prostate cancer. Primary hormonal treatment.
Cancer. 1993 Feb 1;71(3 Suppl):1050-8. doi: 10.1002/1097-0142(19930201)71:3+<1050::aid-cncr2820711425>3.0.co;2-#.
5
Changes in prostate cancer incidence and treatment in USA.美国前列腺癌发病率及治疗情况的变化
Lancet. 1994 Jan 29;343(8892):251-4. doi: 10.1016/s0140-6736(94)91109-6.
6
Complete remission of hormone refractory adenocarcinoma of the prostate in response to withdrawal of diethylstilbestrol.
J Urol. 1995 Jun;153(6):1944-5.
7
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.转移性雄激素非依赖型前列腺癌中雄激素受体基因的突变
N Engl J Med. 1995 May 25;332(21):1393-8. doi: 10.1056/NEJM199505253322101.
8
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.氟他胺撤药综合征：其对激素难治性前列腺癌临床试验的影响。
J Clin Oncol. 1993 Aug;11(8):1566-72. doi: 10.1200/JCO.1993.11.8.1566.
9
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.间歇性雄激素抑制对雄激素依赖性肿瘤的影响。细胞凋亡与血清前列腺特异性抗原
Cancer. 1993 May 1;71(9):2782-90. doi: 10.1002/1097-0142(19930501)71:9<2782::aid-cncr2820710916>3.0.co;2-z.
10
Prostate cancer in the era of prostate-specific antigen.
Curr Opin Oncol. 1995 May;7(3):281-91. doi: 10.1097/00001622-199505000-00014.